[Painful myoedema caused by rhabdomyolysis: a proposal of a new integrated therapeutic treatment].
Bagnoli
L
L
III Divisione di Medicina Interna, Ospedale Santa Maria Annunziata, Firenze.
Meucci
I
I
Francolini
E
E
Menegazzo
G
G
Ghetti
A
A
D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001132:Arm; D003131:Combined Modality Therapy; D062787:Drug Overdose; D004487:Edema / Q000209:etiology* / Q000601:surgery / Q000628:therapy; D003932:Heroin / Q000009:adverse effects*; D006556:Heroin Dependence / Q000150:complications*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D009135:Muscular Diseases / Q000209:etiology* / Q000601:surgery / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000150:complications / Q000628:therapy; D013577:Syndrome
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D003932:Heroin; D008775:Methylprednisolone
Mioedema doloroso da rabdomiolisi: proposta di un nuovo trattamento terapeutico integrato.